MR弹性成像在诊断临床显著门静脉高压方面优于剪切波弹性成像
前瞻性研究纳入36例肝病患者,以肝静脉压力梯度为参考,评估2D/3D MR弹性成像与剪切波弹性成像测量肝、脾硬度及脾体积诊断临床显著门静脉高压的性能;3D MR弹性成像脾硬度与肝静脉压力梯度相关性最强(r=0.686),诊断AUC最高(0.911),显著优于剪切波弹性成像。
要点
- 3D MR弹性成像脾硬度诊断临床显著门静脉高压AUC为0.911,优于2D MR弹性成像脾硬度(AUC 0.845)和3D MR弹性成像肝硬度(AUC 0.804)。
- 剪切波弹性成像脾硬度诊断性能较差(AUC 0.583),脾体积预测性能尚可(AUC 0.738)。
- 3D MR弹性成像脾硬度显著优于剪切波弹性成像肝/脾硬度(p≤0.021)。
核心结论
- 3D MR弹性成像测量的脾硬度诊断临床显著门静脉高压优于剪切波弹性成像,脾硬度似乎是评估门静脉高压严重程度的有用生物标志物,这些结果需要进一步验证。
研究设计与样本
- 前瞻性研究,纳入36例肝病患者(男22例、女14例,平均年龄55±14岁),均接受2D/3D MR弹性成像和剪切波弹性成像测量肝、脾硬度及脾体积,并以肝静脉压力梯度测量为参考标准。
诊断标准与关键数值
- 3D MR弹性成像脾硬度与肝静脉压力梯度相关性最强(r=0.686,p<0.001),其次为2D MR弹性成像脾硬度(r=0.476,p=0.004)。
- 诊断临床显著门静脉高压的AUC:3D MR弹性成像脾硬度0.911,2D MR弹性成像脾硬度0.845,3D MR弹性成像肝硬度0.804,脾体积0.738,剪切波弹性成像脾硬度0.583。
- 3D MR弹性成像脾硬度诊断临床显著门静脉高压显著优于剪切波弹性成像肝/脾硬度(p≤0.021)。
局限性
- 原文结论指出这些结果需要进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Portal hypertension (PH) is associated with complications such as ascites and esophageal varices and is typically diagnosed through invasive hepatic venous pressure gradient (HVPG) measurement, which is not widely available. In this study, we aim to assess the diagnostic performance of 2D/3D MR elastography (MRE) and shear wave elastography (SWE) measures of liver and spleen stiffness (LS and SS) and spleen volume, to noninvasively diagnose clinically significant portal hypertension (CSPH) using HVPG measurement as the reference.
METHODS: In this prospective study, patients with liver disease underwent 2D/3D MRE and SWE of the liver and spleen, as well as HVPG measurement. The correlation between MRE/SWE measures of LS/SS and spleen volume with HVPG was assessed. ROC analysis was used to determine the utility of MRE, SWE, and spleen volume for diagnosing CSPH.
RESULTS: Thirty-six patients (M/F 22/14, mean age 55 ± 14 years) were included. Of the evaluated parameters, 3D MRE SS had the strongest correlation with HVPG (r = 0.686, p < 0.001), followed by 2D MRE SS (r = 0.476, p = 0.004). 3D MRE SS displayed the best performance for diagnosis of CSPH (AUC = 0.911) followed by 2D MRE SS (AUC = 0.845) and 3D MRE LS (AUC = 0.804). SWE SS showed poor performance for diagnosis of CSPH (AUC = 0.583) while spleen volume was a fair predictor (AUC = 0.738). 3D MRE SS was significantly superior to SWE LS/SS (p ≤ 0.021) for the diagnosis of CSPH.
CONCLUSION: SS measured with 3D MRE outperforms SWE for the diagnosis of CSPH. SS appears to be a useful biomarker for assessing PH severity. These results need further validation.
KEY POINTS: • Spleen stiffness measured with 2D and 3D MR elastography correlates significantly with hepatic venous pressure gradient measurement. • Spleen stiffness measured with 3D MR elastography demonstrates excellent performance for the diagnosis of clinically significant portal hypertension (AUC 0.911). • Spleen stiffness measured with 3D MR elastography outperforms liver and spleen stiffness measured with shear wave elastography for diagnosis of clinically significant portal hypertension.
引用
- Kennedy, Stocker, Carbonell, et al. MR elastography outperforms shear wave elastography for the diagnosis of clinically significant portal hypertension. Eur Radiol. 2022. PMID: 35727321. doi:10.1007/s00330-022-08935-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。